{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:18:01Z","timestamp":1761664681623,"version":"3.40.5"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,3,8]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Maternally inherited diabetes and deafness (MIDD) is a rare genetic disorder arising from mitochondrial DNA mutations, characterized by a combination of diabetes mellitus and sensorineural deafness. It is known that MIDD patients with cardiomyopathy have a poor prognosis, but there are no established guidelines for the diagnosis and follow-up of cardiomyopathy in MIDD patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>Patient 1 was a 48-year-old woman who visited the hospital with cardiomegaly and had been taking oral hypoglycemic agents for 8 years. Patient 2 was a 21-year-old man, the son of patient 1, who visited the hospital for genetic screening. Patient 2 was also diagnosed diabetes mellitus 2 years ago.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>Patient 1 was found to have restrictive cardiomyopathy on echocardiography and underwent endomyocardial biopsy and genetic testing to determine the etiology. The m.3243A&gt;G mutation was confirmed and she was diagnosed with MIDD accompanied with diabetes and hearing loss. Additionally, patient 2 had m.3243 A&gt;G mutation and was diagnosed with MIDD due to diabetes and hearing loss.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Because MIDD does not have a specific treatment, patient 1 took ubidecarenone (coenzyme Q10), acetylcarnitine, and multivitamin along with the treatment for diabetes control and heart failure. Patient 2 was taking ubidecarenone (coenzyme Q10), acetylcarnitine, and multivitamin along with treatment for diabetes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>She subsequently underwent routine transthoracic echocardiography, and a progressive decline in global longitudinal strain (GLS) was first observed, followed by a worsening of the patient\u2019s clinical situation. Patient 2 had concentric remodeling and decreased GLS. On periodic echocardiography, GLS decreased at a very slow rate, and the patient\u2019s clinical course was stable.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>The findings of this report contribute to the understanding of the clinical course of MIDD-associated cardiomyopathy and highlight the potential of GLS as a sensitive marker for disease progression.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000037447","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T20:03:20Z","timestamp":1709928200000},"page":"e37447","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Chronological change of left ventricular global longitudinal strain in patients with maternally inherited diabetes and deafness: A case series"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6724-4227","authenticated-orcid":false,"given":"Jeong-Sook","family":"Seo","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Busan Paik Hospital, Inje University, Busan, South Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/07853890510007188","article-title":"Molecular mechanisms of mitochondrial diabetes (MIDD).","volume":"37","author":"Maassen","year":"2005","journal-title":"Ann Med"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.braindev.2004.01.002","article-title":"Clinical features of A3243G mitochondrial tRNA mutation.","volume":"26","author":"Chae","year":"2004","journal-title":"Brain Dev"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0022-510X(02)00048-5","article-title":"External ophthalmoplegia with severe progressive multiorgan involvement associated with the mtDNA A3243G mutation.","volume":"197","author":"Hansrote","year":"2002","journal-title":"J Neurol Sci"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1212\/WNL.46.5.1334","article-title":"A MERRF\/PEO overlap syndrome associated with the mitochondrial DNA 3243 mutation.","volume":"46","author":"Verma","year":"1996","journal-title":"Neurology"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/348651a0","article-title":"A mutation in the tRNA(Leu) (UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies.","volume":"348","author":"Goto","year":"1990","journal-title":"Nature"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1136\/jnnp-2012-303528","article-title":"The UK MRC Mitochondrial Disease Patient Cohort Study: clinical phenotypes associated with the m.3243A>G mutation-implications for diagnosis and management.","volume":"84","author":"Nesbitt","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2261-2-12","article-title":"Cardiac abnormalities in patients with mitochondrial DNA mutation 3243A>G.","volume":"2","author":"Majamaa-Voltti","year":"2002","journal-title":"BMC Cardiovasc Disord"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1212\/WNL.0b013e31827b1a2f","article-title":"High risk of severe cardiac adverse events in patients with mitochondrial m.3243A>G mutation.","volume":"80","author":"Malfatti","year":"2013","journal-title":"Neurology"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/chd.12634","article-title":"Mitochondrial DNA mutation \u201cm.3243A>G\u201d\u2014heterogeneous clinical picture for cardiologists (\u201cm.3243A>G\u201d: a phenotypic chameleon).","volume":"13","author":"Niedermayr","year":"2018","journal-title":"Congenit Heart Dis"},{"key":"R10-20250503","first-page":"34","article-title":"Cardiovascular manifestations of mitochondrial disease.","volume":"8","author":"Duran","year":"2019","journal-title":"Biology (Basel)"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"128","DOI":"10.17712\/nsj.2021.2.20200145","article-title":"The non-syndromic clinical spectrums of mtDNA 3243A>G mutation.","volume":"26","author":"Shen","year":"2021","journal-title":"Neurosciences (Riyadh)"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0195-668X(02)00387-1","article-title":"Cardiomyopathy in children with mitochondrial disease; clinical course and cardiological findings.","volume":"24","author":"Holmgren","year":"2003","journal-title":"Eur Heart J"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1093\/eurheartj\/ehv306","article-title":"Sudden adult death syndrome in m.3243A>G-related mitochondrial disease: an unrecognized clinical entity in young, asymptomatic adults.","volume":"37","author":"Ng","year":"2016","journal-title":"Eur Heart J"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10545-016-0001-7","article-title":"Is 2D speckle tracking echocardiography useful for detecting and monitoring myocardial dysfunction in adult m.3243A>G carriers? \u2013 a retrospective pilot study.","volume":"40","author":"Koene","year":"2017","journal-title":"J Inherit Metab Dis"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ymgme.2022.05.004","article-title":"Screening and prevalence of cardiac abnormalities on electro- and echocardiography in a large cohort of patients with mitochondrial disease.","volume":"136","author":"Hendrix","year":"2022","journal-title":"Mol Genet Metab"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"ytad073","DOI":"10.1093\/ehjcr\/ytad073","article-title":"Bilateral deafness, diabetes, and different types of cardiomyopathy in family members with m.3243A > g mutation: a case report.","volume":"7","author":"Seiler","year":"2023","journal-title":"Eur Heart J Case Rep"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037447","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:22:36Z","timestamp":1746318156000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,8]]},"references-count":16,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000037447","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2024,3,8]]}}}